Pure Global

“Vircell” HERPES SIMPLEX 1 VIRCLIA IgG MONOTEST - Taiwan Registration 9af3784351d349dd4f1bca6c41961a1d

Access comprehensive regulatory information for “Vircell” HERPES SIMPLEX 1 VIRCLIA IgG MONOTEST in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9af3784351d349dd4f1bca6c41961a1d and manufactured by VIRCELL, S.L. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
9af3784351d349dd4f1bca6c41961a1d
Registration Details
Taiwan FDA Registration: 9af3784351d349dd4f1bca6c41961a1d
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Vircell” HERPES SIMPLEX 1 VIRCLIA IgG MONOTEST
TW: “凡賽爾” 第一型單純皰疹毒化學冷光免疫分析IgG試劑組
Risk Class 2
MD

Registration Details

9af3784351d349dd4f1bca6c41961a1d

Ministry of Health Medical Device Import No. 032170

DHA05603217006

Company Information

Spain

Product Details

This product is an indirect chemiluminescent immunoassay (CLIA) reagent with ThunderBolt Immunoassay Analyzer for the qualitative detection of anti-herpes simplex virus IgG antibodies in human serum/plasma.

C Immunology and microbiology devices

C3305 Herpes simplex virus serum reagent

Imported from abroad

Dates and Status

Feb 13, 2019

Feb 13, 2024